Transcranial Magnetic Stimulation in Mild Cognitive Impairment and Alzheimer Disease
NCT ID: NCT04771845
Last Updated: 2021-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
73 participants
OBSERVATIONAL
2008-05-01
2020-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory
NCT04294888
Network-guided TMS in Early Alzheimer's Disease
NCT04549155
Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease
NCT02908815
Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients
NCT01504958
Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
NCT06597942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EEG-grid-guided-TMS
Patients with Alzheimer disease and mild cognitive impairment receiving TMS using electroencephalogram grid guided navigation
Transcranial Magnetic Stimulation
Magnetic stimulation to alter neural activity
MRI-guided-TMS
Patients with Alzheimer disease and mild cognitive impairment receiving TMS using MRI guided navigation
Transcranial Magnetic Stimulation
Magnetic stimulation to alter neural activity
NACC controls
National Alzheimer's Coordinating Center matched controls
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial Magnetic Stimulation
Magnetic stimulation to alter neural activity
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients meeting the National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer's Disease and Related Disorders Association (NINCDS- ADRDA) criteria for mild cognitive impairment.
* Patients must have undergone at least two standardized neurocognitive batteries before and after beginning TMS.
* Patients must have received greater than or equal to five (5) TMS sessions in less than one year.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The New York Memory Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gayatri Devi, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gayatri Devi, MD
Role: PRINCIPAL_INVESTIGATOR
NY Memory
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-0812
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.